Live Breaking News & Updates on Frontier Medicines

Stay updated with breaking news from Frontier medicines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PennyMac Mortgage Investment Trust Announces SiSi Pouraghabagher Joined Its Board of Trustees

PennyMac Mortgage Investment Trust Announces SiSi Pouraghabagher Joined Its Board of Trustees
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

California , United-states , America , David-spector , Luis-obispo , Sisi-pouraghabagher , Auto-financial-corporation , Pennymac-mortgage-investment-trust , Deloitte , Pennymac-mortgage-investment , Board-of-trustees , Audit-committee

AACR: KRAS inhibitors pop in preclinical data debuts

AACR: KRAS inhibitors pop in preclinical data debuts
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United-states , San-diego , California , American , Andrew-krivoshik , Amgen-lumakras , Johns-hopkins-university , American-association-for-cancer-research , Bristol-myers-squibb , Verastem-oncology , Frontier-medicines , Quanta-therapeutics

Adagrasib, Cetuximab May Benefit KRASG12c Colorectal Cancer Patients

Adagrasib, Cetuximab May Benefit KRASG12c Colorectal Cancer Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United-states , Texas , American , Redx-pharma , Daiichi-sankyo , Bristol-myers-squibb-medarex , Genentech-roche , Eli-lilly , Scott-kopetz , Navire-pharma , Astrazeneca-medimmune , Lutris-pharma

Adagrasib/Cetuximab Combo Has Activity in KRAS G12C+ Locally Advanced or mCRC

Adagrasib plus cetuximab elicited a 34% objective response rate in patients with previously treated KRAS G12C-mutant advanced colorectal cancer. ....

Texas , United-states , Houston , San-diego , California , American , Daiichi-sankyo , Bristol-meyers-squibb , Redx-pharma , Eli-lilly , Navire-pharma , Genentech-roche